数字健康技术在早期帕金森病中的可接受性:来自WATCH-PD的经验教训
T Kangarloo1, R D Latzman1, J L Adams2,3
1Takeda Pharmaceuticals, Cambridge, MA, United States.
Frontiers in digital health
|September 10, 2024
概括
数字健康技术 (DHT) 是可以接受的帕金森病 (PD) 患者. 早期PD患者与健康成年人相比,表现出类似的设备熟练程度和对DHT的积极反.
科学领域:
- 数字健康数字健康
- 神经学 神经学
- 临床试验 临床试验
背景情况:
- 数字健康技术 (DHT) 在临床试验中提供客观评估,但在参与者接受度和易用性方面面临挑战.
- 了解患者群体中的设备熟练程度对于扩展DHT使用至关重要.
研究的目的:
- 评估参与者对DHT (可穿戴传感器和移动应用程序) 在帕金森病 (WATCH-PD) 临床和家庭可穿戴评估研究中的可接受性和可用性的反.
- 与健康对照组相比,评估早期帕金森病 (PD) 患者的设备熟练程度.
主要方法:
- 观察PD研究在美国17个地区招募了82名患有PD的参与者和50名对照者,并在12个月内跟踪他们.
- 参与者的设备熟练程度在基线时使用移动设备熟练度问卷 (MDPQ) 进行了评估.
主要成果:
- 在PD患者 (20.6 ± 2.91) 和健康对照组 (21.5 ± 2.94;p = 0.10) 之间,平均MDPQ得分没有显著差异.
- 问卷调查结果表明,参与者在整个研究过程中对DHT的舒适性和使用的看法总体上是积极的,不管组.
结论:
- 这项研究是第一个评估患者对DHTs的反在早期PD的纵向观察性研究中.
- 患有PD的人对DHT的设备熟练程度和可接受性与神经健康的老年人相似.
- 参与者报告说,他们对WATCH-PD研究中使用的DHTs的总体看法很好.
相关概念视频
Parkinson's Disease: Treatment
237
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
237
Parkinson's Disease: Overview
498
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
498


